Milestone
VC Fund
Shanghai, China
Milestone is an asset management organization.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Milestone invests in
Health CareBiotechnologyMedicalVideoMobile
Stages Milestone invests in
Series ASeries CVenture - Series UnknownSeedAngel
Countries Milestone invests in
ChinaSouth Korea
Investment Focus
Industry
- Health Care 3 (25%)
- Biotechnology 3 (25%)
- Medical 2 (17%)
- Video 1 (8%)
- Mobile 1 (8%)
Stage
- Series A 4 (33%)
- Series C 2 (17%)
- Venture - Series Unknown 2 (17%)
- Seed 1 (8%)
- Angel 1 (8%)
Country
- China 7 (58%)
- South Korea 2 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ROKIT Healthcare provides hardware, software, and application support. Their custom fabrication technologies deliver solutions to the design, creation, and applications of three-dimensional systems. They provide suffering patients and humans with a hyper-personalized medical organ regeneration solution. They apply artificial intelligence and 3dbioprinting technology to regenerate the skin and cartilage organs through surgery for patients. | $42.5M / Post-IPO Equity / Mar 10, 2026 | ||
| AriBio is a biotechnology firm dedicated to developing therapeutic solutions for neurodegenerative disorders. At AriBio, polypharmacology is strengthened by the capabilities of advanced AI technologies. Utilizing the ARIDD™ platform, the company explores extensive molecular databases, forecasting interactions that encompass various targets andmechanisms. By harnessing AI, AriBio strives to enhance drug efficacy and broaden potential therapeutic applications. ARIDD™ serves as a drug development platform that enhances the discovery and creation of polypharmacological medications. | $83.6M / Venture - Series Unknown / Feb 18, 2022 | ||
| Ugion is an augmented and virtual reality R&D company that provides marketing display, amusement interaction, and education services. | Series A / Jan 11, 2022 | ||
| ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | $100M / Series C / Jan 01, 2022 | ||
| ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | $100M / Venture - Series Unknown / Dec 31, 2021 | ||
| ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | $25M / Series B / Oct 10, 2020 | ||
| Cosemitech is a cutting-edge semiconductor solution provider. The R&D team has more than 12 years of experience in automotive electronics IC development. The chips developed by the team are widely used in Europe, Europe, Germany, France, Italy and the United States. On the car. Committed to providing customers with power devices, industrialcontrol, automotive electronics solutions. From sensor technology, energy management and energy-saving technologies, industrial control to automotive electronics, from work to entertainment, Yirui Semiconductor will strive to contribute and play an active and innovative role in enriching people's lives. | $1.4M / Seed / Jun 04, 2019 | ||
|
Seek-Data
|
Seek-Data is a smart quantitative investment research company. | $730K / Angel / Jan 08, 2019 | |
| ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells. | Series A / Apr 11, 2018 | ||
| Shanghai Ulucu Electronic Technology Co.,Ltd. (悠络客电子科技) is a cloud-based video monitoring and network monitoring operator that provides chain enterprises, logistics enterprises, education institutions and governments with network monitoring operation services. Its services include the research and development, selling, installation, platformoperation, after-sales services, securities services of software and hardware and other whole solutions. Ulucu has a strong independent research and development team with achievements in embedded technology of hardware to streaming media transmission technology, P2P transmission technology, cloud server technology, and more.. Its products and technology has received many national invention patents. Ulucu aims to establish a strong and complete national service system. Currently, Ulucu has over 300 national service network stations including after-sales service stations and joint service providers which cover all provinces and cities. | $12M / Series C / Jan 08, 2018 | ||
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
SaaS Investors
99,274 investors
Health Care Investors
43,014 investors
Media (entertainment) Investors
29,128 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
Mobile Investors
12,672 investors
SaaS VC Funds
61,208 investors
Health Care VC Funds
32,370 investors
FAQ
What does Milestone invest in?
Milestone invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series C stage. Most of the 12 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Milestone last invest?
The most recent investment recorded for Milestone closed in Mar 2026. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
